Why the study?
Females with type 2 diabetes develop greater vascular dysfunction than males, prompting investigation into whether estrogen preserves mesenteric arterial vasorelaxation in female UCD-T2DM rats at an early prediabetic state.
Does 17β-estradiol improve acetylcholine-induced vasorelaxation of mesenteric arteries in ovariectomized prediabetic UCD-T2DM rats?
Does 17β-estradiol improve acetylcholine-induced vasorelaxation of mesenteric arteries in ovariectomized prediabetic UCD-T2DM rats?
17β-estradiol treatment protects mesenteric arteries from early vascular dysfunction in ovariectomized prediabetic female rats, partly by improving nitric oxide contribution and insulin signaling.
Answers are grounded in this paper and cite their sources.
E2 enhances vasorelaxation in this prediabetic OVX rat model; leaves open translation to postmenopausal women.
We recently reported sex differences in mesenteric arterial function of the UC Davis type-2 diabetes mellitus (UCD-T2DM) rats as early as the prediabetic state. We reported that mesenteric arteries (MA) from prediabetic male rats exhibited a greater impairment compared to that in prediabetic females. However, when females became diabetic, they exhibited a greater vascular dysfunction than males. Thus, the aim of this study was to investigate whether the female sex hormone, estrogen preserves mesenteric arterial vasorelaxation in UCD-T2DM female rats at an early prediabetic state. Age-matched female Sprague Dawley and prediabetic (PD) UCD-T2DM rats were ovariectomized (OVX) and subcutaneously implanted with either placebo or 17β-estradiol (E 2, 1.5 mg) pellets for 45 days. We assessed the contribution of endothelium-derived relaxing factors (EDRF) to acetylcholine (ACh)-induced vasorelaxation, using pharmacological inhibitors. Responses to sodium nitroprusside (SNP) and phenylephrine (PE) were also measured. Additionally, metabolic parameters and expression of some targets associated with vascular and insulin signaling were determined. We demonstrated that the responses to ACh and SNP were severely impaired in the prediabetic state (PD OVX) rats, while E 2 treatment restored vasorelaxation in the PD OVX + E 2 . Moreover, the responses to PE was significantly enhanced in MA of PD OVX groups, regardless of placebo or E 2 treatment. Overall, our data suggest that 1) the impairment of ACh responses in PD OVX rats may, in part, result from the elevated contractile responses to PE, loss of contribution of endothelium-dependent hyperpolarization (EDH) to vasorelaxation, and a decreased sensitivity of MA to nitric oxide (NO), and 2) the basis for the protective effects of E 2 may be partly attributed to the elevation of the NO contribution to vasorelaxation and its interaction with MA as well as potential improvement of insulin signaling. Here, we provide the first evidence of the role of E 2 in protecting MA from early vascular dysfunction in prediabetic female rats.
No takes yet. Share an insight, caveat, or question.
Razan et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: